drugset / Trial / NCT07586969

Modulation of Hyperandrogenic Anovulation Through Fenugreek Seeds

NCT07586969 ↗

Completed 70 enrolled University of Lahore
RandomizedParallel-groupOpen-labelSupportive care

Summary

Hyperandrogenic anovulation is a common gynecological illness that impacts the ovaries, vagina and uterus. According to Statistics, in Pakistan 17.6% of individuals seeking treatment at infertility clinics were found to be affected by hyperandrogenic anovulation. Studies indicate that fenugreek seeds have the potential to improve insulin sensitivity, control hormone levels, namely the increased androgens linked to hyperandrogenic anovulation, and promote ovulation, a process commonly interrupted in individuals with hyperandrogenic anovulation. In order to create a therapy plan that is both affordable and easily accessible for women who suffer from hyperandrogenic anovulation, this study aims to determine the therapeutic efficacy of fenugreek seed powder in reducing symptoms related to the illness. Furthermore, it aims to increase knowledge on the extensive utilization of fenugreek seed powder as a natural treatment for hyperandrogenic anovulation.

Timeline

Start
2024-09-11
Primary completion
2024-11-11
Completion
2024-12-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 500 mg —